NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $131.12 +22.53 (+20.75%) Closing price 04:00 PM EasternExtended Trading$131.12 0.00 (0.00%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iRhythm Technologies Stock (NASDAQ:IRTC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get iRhythm Technologies alerts:Sign Up Key Stats Today's Range$119.08▼$133.2050-Day Range$96.84▼$113.9152-Week Range$55.92▼$139.00Volume2.13 million shsAverage Volume465,473 shsMarket Capitalization$4.19 billionP/E RatioN/ADividend YieldN/APrice Target$128.55Consensus RatingModerate Buy Company OverviewiRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More… iRhythm Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreIRTC MarketRank™: iRhythm Technologies scored higher than 19% of companies evaluated by MarketBeat, and ranked 828th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingModerate Buy Consensus RatingiRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.91, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageiRhythm Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($1.98) to ($1.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -36.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -36.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 19.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.04% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 7.5.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 6.48%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted10.04% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 7.5.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 6.48%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News Sentiment0.71 News SentimentiRhythm Technologies has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 27 news articles for iRhythm Technologies this week, compared to 6 articles on an average week.Search Interest2 people have searched for IRTC on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.68% of the stock of iRhythm Technologies is held by insiders.Read more about iRhythm Technologies' insider trading history. Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Stock News HeadlinesWells Fargo Upgrades iRhythm Technologies (IRTC)May 2 at 7:07 PM | msn.comWells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s ThrilledMay 2 at 2:06 PM | msn.comBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.May 2, 2025 | Golden Portfolio (Ad)Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among AnalystsMay 2 at 2:01 PM | benzinga.comiRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is OptimisticMay 2 at 4:01 AM | finance.yahoo.comiRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call TranscriptMay 1 at 10:06 PM | seekingalpha.comiRhythm Technologies, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 1 at 9:15 PM | seekingalpha.comiRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia DetectionMay 1 at 4:10 PM | globenewswire.comSee More Headlines IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $90.17 at the beginning of 2025. Since then, IRTC stock has increased by 45.4% and is now trading at $131.12. View the best growth stocks for 2025 here. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its quarterly earnings results on Thursday, May, 1st. The company reported ($0.95) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.89) by $0.06. The firm's quarterly revenue was up 20.3% on a year-over-year basis. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' top institutional investors include Bessemer Group Inc. (1.83%), Stephens Investment Management Group LLC (1.63%), Allspring Global Investments Holdings LLC (1.62%) and Bank of New York Mellon Corp (1.12%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Chad Patterson, Patrick Michael Murphy, Daniel G Wilson, Douglas Devine, Minang Turakhia, Brice Bobzien, Sumi Shrishrimal, Abhijit Y Talwalkar, Mervin Smith, Marc W Rosenbaum and Merz Cathleen Noel Bairey. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings5/01/2025Today5/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRTC CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees1,790Year FoundedN/APrice Target and Rating Average Stock Price Target$129.73 High Stock Price Target$152.00 Low Stock Price Target$100.00 Potential Upside/Downside-0.7%Consensus RatingModerate Buy Rating Score (0-4)2.91 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($3.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-123,410,000.00 Net Margins-19.14% Pretax Margin-26.78% Return on Equity-118.83% Return on Assets-11.34% Debt Debt-to-Equity Ratio9.00 Current Ratio6.27 Quick Ratio6.12 Sales & Book Value Annual Sales$591.84 million Price / Sales7.05 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book19.08Miscellaneous Outstanding Shares31,920,000Free Float31,085,000Market Cap$4.17 billion OptionableOptionable Beta1.45 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (NASDAQ:IRTC) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.